as on November 7, 2025 at 4:01 pm IST
Day's Low
Day's High
1.90%
Downside
7.68%
Upside
52 Week's Low
52 Week's High
1.90%
Downside
69.01%
Upside
as on November 7, 2025 at 4:01 pm IST
Market Cap
₹170.93 Cr
Return on Equity (ROE)
11.45
PE Ratio (TTM)
6.48
Return on capital employed (ROCE)
14.96
Industry PE ratio
41.8
Beta (LTM)
1.13
P/B Ratio
1.2
Dividend Yield
0PEG Ratio
1.86
Quarterly Earnings Growth YOY
130.78
EPS (TTM)
9.27
Sector
Pharmaceuticals
Book Value
81.48
Technical Analysis
Bearish
View Technical Analysis
as on November 7, 2025 at 4:01 pm IST
Alpa Laboratories Ltd in the last 5 years
Lowest (6.48x)
November 7, 2025
Today (6.48x)
November 7, 2025
Industry (41.80x)
November 7, 2025
Highest (65.88x)
July 22, 2019
Today’s Price to Earnings Ratio: 6.48x
Compare market cap, revenue, PE, and other key metrics of Alpa Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 170.93 | 21.45% | 0.50 | 19 | 112 | |
| NA | 39.35 | 75.3% | 0.00 | 2 | 120 | |
| 2,518.59 | -9.56% | 0.72 | -567 | 1,283 | ||
| NA | 15.00 | 66.99% | 0.00 | -1 | NA | |
| NA | 412.94 | 2.59% | 0.00 | NA | NA |
Search interest for Alpa Laboratories Ltd Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:38% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Alpa Laboratories Ltd.
Alpa Laboratories Ltd’s net profit jumped 130.78% since last year same period to ₹11.77Cr in the Q1 2025-2026. On a quarterly growth basis, Alpa Laboratories Ltd has generated 655.19% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -2.12 Cr → 11.77 Cr (in ₹), with an average increase of 118.0% per quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 42.34% to 42.35% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 57.29% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Divis Laboratories Ltd has given 15.5% return, outperforming this stock by 38.3%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 111.3% return, outperforming this stock by 62.7%
Price Dip
![]()
In the last 7 days, ALPA stock has moved down by -4.9%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.36% to 0.35% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 42.4 Cr → 31.06 Cr (in ₹), with an average decrease of 26.8% per quarter
| Organisation | Alpa Laboratories Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| CEO | Mahendra Singh Chawla |
| E-voting on shares | Click here to vote |
Alpa Laboratories Ltd share price today stands at ₹81.24 as on at the close of the market. Alpa Laboratories Ltd share today touched a day high of ₹87.48 and a low of ₹79.7.
Alpa Laboratories Ltd touched a 52 week high of ₹137.3 and a 52 week low of ₹79.7. Alpa Laboratories Ltd share price today i.e. is closed at ₹81.24, which is -40.83% down from its 52 week high and 1.93% up from its 52 week low.
Alpa Laboratories Ltd market capitalisation is ₹170.93 Cr as on .
To buy Alpa Laboratories Ltd shares, you need to follow these steps:
Alpa Laboratories Ltd trading volume is 73.79K as on . This means that 73.79K shares of Alpa Laboratories Ltd were bought and sold on the stock market during today's trading session.